Reporting of Adverse Events in Patients Treated With New Oral Anticoagulants

Warfarin - How Good Are we at Maintaining Target Range ?

NCT01081327 ·Status: COMPLETED

Very Low Dose Oral Anticoagulation and Thromboembolic and Bleeding Complications

NCT00528671 ·Status: TERMINATED ·Phase: PHASE4

Oral Anticoagulant Therapy for Venous Thrombosis - SCOR in Thrombosis

NCT00005684 ·Status: COMPLETED

Influence of ABCB1 Polymorphisms on Plasma Concentrations of New Oral Anticoagulants in Case of Serious Adverse Events

NCT02103101 ·Status: COMPLETED ·Phase: NA

Oral Anticoagulant Discontinuation, Adherence Patterns, Hospitalizations and Costs in Non-Valvular Atrial Fibrillation (NVAF) Patients

NCT02792335 ·Status: COMPLETED

Precision Medicine Platform for Novel Oral Anticoagulants

NCT04056143 ·Status: UNKNOWN

Comparison of the Effect of Warfarin and Direct Oral Anticoagulants

NCT06269302 ·Status: COMPLETED

Efficacy and Safety of Low-molecular Weight Heparin for Thromboprophylaxis in Acutely Ill Medical Patients

NCT00311753 ·Status: COMPLETED ·Phase: PHASE3

Measuring the Incidence of Hospital Readmissions Based on Adverse Drug Events

NCT02074085 ·Status: UNKNOWN

Direct Oral Anticoagulants and Venous Thromboembolism

NCT02833987 ·Status: COMPLETED

Anticoagulation Length of ThErapy and Risk of New Adverse evenTs In Venous thromboEmbolism Study

NCT03292666 ·Status: COMPLETED

Reversal of the Antithrombotic Action of New Oral Anticoagulants

NCT01478282 ·Status: UNKNOWN ·Phase: PHASE4

Excessive Warfarin Anticoagulation - Causes and Consequences

NCT02761941 ·Status: UNKNOWN

AntiCoagulation Tracking InterVention and Evaluation

NCT04059965 ·Status: WITHDRAWN ·Phase: NA

Predicting Bleeding Risk on Anticoagulant Therapy for Venous Thromboembolism

NCT00788736 ·Status: COMPLETED

Early Versus Late Resumption of Anticoagulation in Patients With Both High Thrombosis Risk and Major HEmoRrhage

NCT02091479 ·Status: TERMINATED ·Phase: PHASE3

Register for New Oral Anticoagulants

NCT01588119 ·Status: UNKNOWN

Enhancing the Safety of Warfarin in Nursing Homes

NCT00682773 ·Status: COMPLETED ·Phase: NA

Impact of Renal Function Availability to Community Pharmacist for Dispensing Direct Oral Anticoagulant in Ambulatory Patients on Bleeding Occurrence

NCT06739603 ·Status: NOT_YET_RECRUITING ·Phase: NA

Pharmacokinetics of Dalteparin in Patients With Impaired Renal Function

NCT00264693 ·Status: COMPLETED

Retrospective Study on Characteristics and Outcomes in Hospitalised Patients Treated With Ondexxya

NCT05898412 ·Status: COMPLETED

Clotting Genetic Variants, Hormones, and Venous Thrombosis

NCT00094185 ·Status: COMPLETED

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Netherlands)

NCT01947985 ·Status: COMPLETED

Risk, Predictors, Impact and Outcome of Anticoagulation-associated Abnormal Menstrual Bleeding

NCT04748393 ·Status: TERMINATED

Bleeding Risk Evaluation in Haemophilia Patients Under Antiplatelet Therapies

NCT03157154 ·Status: COMPLETED